Laboratorio Reig (RJF) | Stock Overview & Key Data
Laboratorio Reig Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €55.00 on November 25, 2002
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Laboratorio Reig
RJF
|
220.63M Mid-cap | -1.48% | 5.12% | -1.11% | -10.10% | -0.37% | -8.56% | 3.89% | -52.74% | -22.61% | -61.19% | -89.23% |
|
Laboratorios
ROVI
|
4.34B Large-cap | -4.70% | 3.25% | 11.63% | 25.93% | 28.02% | 58.55% | 101.84% | 68.26% | 449.09% | 1,459.62% | 743.04% |
|
Almirall S.A
ALM
|
2.76B Large-cap | -0.47% | 11.78% | -0.16% | 0.79% | -1.40% | 31.68% | 36.63% | -2.60% | -9.40% | 65.19% | -15.31% |
|
Faes Farma S.A
FAE
|
1.51B Large-cap | -2.24% | 6.90% | -6.07% | 6.90% | -8.05% | 15.38% | 50.00% | 38.33% | 75.18% | 77.12% | -48.94% |
| 49.24M Small-cap | 37.20% | 27.36% | 54.11% | 60.71% | 37.76% | 122.04% | 125.00% | 9,542.86% | 743.75% | 743.75% | 743.75% | |
|
Grifols, S.A
GRF
|
6.09B Large-cap | -7.25% | 1.24% | -18.49% | -20.87% | -20.02% | 5.17% | -3.97% | -60.31% | -52.89% | 33.98% | 244.23% |
Ownership & Short Interest
Calculate Your Laboratorio Reig Investment Returns
Long-Term Investment Performance Analysis
Laboratorio Reig stock price in Jul 2016 was €2.95, A €1,000.00 lump sum investment in Laboratorio Reig made 9 years ago would be worth approximately €905.08 today, representing a negative return of -9.49%. This translates to an annualized return (CAGR) of -1.02%.
9 Years 9 Months Investment Scenario (Jul 2016 - Apr 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is RJF's 52-week high and low?
- In the last 52 weeks, Laboratorio Reig reached a high of €3.40 (on June 6, 2025) and a low of €2.32 (on March 12, 2026).
- What is the market cap and P/E ratio for RJF?
- Curious about Laboratorio Reig's size and valuation? Its market capitalization stands at 220.63M. When it comes to valuation, the P/E ratio (trailing twelve months) is 45.17, and the forward P/E (looking ahead) is 22.58.
- Does RJF pay dividends? If so, what's the yield?
- Yes, Laboratorio Reig is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.61%, and the company has paid an average of €0.38 per share annually over the past 3 years.
- Who are Laboratorio Reig's main competitors or similar companies to consider before investing?
When looking at Laboratorio Reig, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Laboratorios
ROVI4.34B Healthcare Drug Manufacturers - Specialty & Generic 58.55% 101.84% Almirall S.A
ALM2.76B Healthcare Drug Manufacturers - Specialty & Generic 31.68% 36.63% Faes Farma S.A
FAE1.51B Healthcare Drug Manufacturers - Specialty & Generic 15.38% 50.00% Labiana Health S.A
LAB49.24M Healthcare Drug Manufacturers - Specialty & Generic 122.04% 125.00% Grifols, S.A
GRF6.09B Healthcare Drug Manufacturers - General 5.17% -3.97% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Laboratorio Reig Jofre S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Laboratorio Reig's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.30%, the Debt to Equity ratio from the most recent quarter is 42.21, and its Gross Profit Margin stands at 61.00%.
- What is the recent revenue and earnings growth for RJF?
- Looking at Laboratorio Reig's growth, its revenue over the trailing twelve months (TTM) was €337M. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.20%, and quarterly earnings saw a YoY growth of 32.60%.
- How much of RJF stock is held by insiders and institutions?
- Wondering who owns Laboratorio Reig stock? Company insiders (like executives and directors) hold about 79.03% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 2.37%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.